• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

长链非编码RNA SH3BP5-AS1在非小细胞肺癌中的预后价值及其对肿瘤进展的调控作用

Prognostic value of LncRNA SH3BP5-AS1 in non-small cell lung cancer and its regulatory effect on tumor progression.

作者信息

Meng Cong, Zang Aihua, Du Fengcai

机构信息

Department of Radiotherapy for Tumors, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.

Department of Ultrasound, Qingdao Municipal Hospital, Qingdao, 266011, Shandong, China.

出版信息

Discov Oncol. 2025 Jun 17;16(1):1126. doi: 10.1007/s12672-025-02906-4.

DOI:10.1007/s12672-025-02906-4
PMID:40523970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12170978/
Abstract

OBJECTIVE

This study aimed to investigate the prognostic significance of SH3BP5-AS1 in non-small cell lung cancer (NSCLC) patients, and also to uncover its function in the progression of NSCLC.

METHODS

100 NSCLC patients were recruited in this study. SH3BP5-AS1 was measured by RT-qPCR. The prognostic significance of SH3BP5-AS1 in NSCLC progression was appraised utilizing the Kaplan-Meier and Cox regression test. CCK-8 was used to detect the proliferative viability of NSCLC cells. The migratory and invasive capabilities of NSCLC cells were evaluated by Transwell assay. The interplay between SH3BP5-AS1 and miR-424-5p was verified by luciferase reporter assay and ENCORI database. The potential target genes of miR-424-5p were inspected by means of bioinformatics analysis.

RESULTS

A reduced SH3BP5-AS1 was manifested in tissues of NSCLC patients and tumor cells. Compared with patients showing SH3BP5-AS1 low-expression, those with SH3BP5-AS1 high-expression possessed a more favorable progression-free survival time. SH3BP5-AS1 might function as an autonomous prognostic biomarker for NSCLC. Upregulation of SH3BP5-AS1 suppressed the proliferation, migration and invasion of NSCLC cells. MiR-424-5p was a downstream target miRNA of SH3BP5-AS1, and luciferase reporter assays verified that SH3BP5-AS1 and miR-424-5p interact. In NSCLC patient tissues, miR-424-5p was upregulated and it exhibited an inverse correlation with SH3BP5-AS1. Elevation of miR-424-5p neutralized the inhibitory effect of SH3BP5-AS1 overexpression on the proliferation, migration, and invasion abilities of NSCLC cells.

CONCLUSION

SH3BP5-AS1 is involved in NSCLC development by targeting its downstream target miRNA miR-424-5p, and it is a latent prognostic indicator for NSCLC.

摘要

目的

本研究旨在探讨SH3BP5-AS1在非小细胞肺癌（NSCLC）患者中的预后意义，并揭示其在NSCLC进展中的作用。

方法

本研究招募了100例NSCLC患者。通过RT-qPCR检测SH3BP5-AS1。利用Kaplan-Meier和Cox回归检验评估SH3BP5-AS1在NSCLC进展中的预后意义。采用CCK-8检测NSCLC细胞的增殖活力。通过Transwell实验评估NSCLC细胞的迁移和侵袭能力。通过荧光素酶报告基因实验和ENCORI数据库验证SH3BP5-AS1与miR-424-5p之间的相互作用。通过生物信息学分析检测miR-424-5p的潜在靶基因。

结果

NSCLC患者组织和肿瘤细胞中SH3BP5-AS1表达降低。与SH3BP5-AS1低表达患者相比，SH3BP5-AS1高表达患者的无进展生存期更有利。SH3BP5-AS1可能作为NSCLC的独立预后生物标志物。SH3BP5-AS1的上调抑制了NSCLC细胞的增殖、迁移和侵袭。MiR-424-5p是SH3BP5-AS1的下游靶miRNA，荧光素酶报告基因实验验证了SH3BP5-AS1与miR-424-5p相互作用。在NSCLC患者组织中，miR-424-5p上调，且与SH3BP5-AS1呈负相关。miR-424-5p的升高抵消了SH3BP5-AS1过表达对NSCLC细胞增殖、迁移和侵袭能力的抑制作用。

结论

SH3BP5-AS1通过靶向其下游靶miRNA miR-424-5p参与NSCLC的发生发展，是NSCLC的潜在预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/efea5e066f84/12672_2025_2906_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/89063a36066d/12672_2025_2906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/941bfd10897a/12672_2025_2906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/dc07c3fb158e/12672_2025_2906_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/7184be7c07e1/12672_2025_2906_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/983920e55e49/12672_2025_2906_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/efea5e066f84/12672_2025_2906_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/89063a36066d/12672_2025_2906_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/941bfd10897a/12672_2025_2906_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/dc07c3fb158e/12672_2025_2906_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/7184be7c07e1/12672_2025_2906_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/983920e55e49/12672_2025_2906_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60b2/12170978/efea5e066f84/12672_2025_2906_Fig6_HTML.jpg

相似文献

1
Prognostic value of LncRNA SH3BP5-AS1 in non-small cell lung cancer and its regulatory effect on tumor progression.长链非编码RNA SH3BP5-AS1在非小细胞肺癌中的预后价值及其对肿瘤进展的调控作用
Discov Oncol. 2025 Jun 17;16(1):1126. doi: 10.1007/s12672-025-02906-4.
2
microRNA-196b-5p expression in cancer tissues is closely associated with clinical and pathological characteristics and prognosis of patients with non-small cell lung cancer.微小RNA-196b-5p在癌组织中的表达与非小细胞肺癌患者的临床病理特征及预后密切相关。
J Cardiothorac Surg. 2025 Jun 18;20(1):264. doi: 10.1186/s13019-025-03508-5.
3
delivery of PBAE/ZIF-8 enhances the sensitivity of colorectal cancer to doxorubicin through sh-LncRNA ASB16-AS1.PBAE/ZIF-8的递送通过sh-LncRNA ASB16-AS1增强了结直肠癌对阿霉素的敏感性。
J Biomater Sci Polym Ed. 2025 Mar;36(4):495-512. doi: 10.1080/09205063.2024.2410060. Epub 2024 Oct 20.
4
LncRNA MBNL1-AS1 functions as an alternative atherosclerosis biomarker in elderly hypertensive patients and regulates vascular smooth muscle cell function.长链非编码RNA MBNL1-AS1作为老年高血压患者动脉粥样硬化的替代生物标志物，并调节血管平滑肌细胞功能。
Minerva Cardiol Angiol. 2025 Jun;73(3):258-266. doi: 10.23736/S2724-5683.24.06619-5. Epub 2024 Oct 8.
5
circ-NOLC1 inhibits the development of cervical cancer by regulating miR-330-5p-PALM signaling axis.环状非编码RNA NOLC1通过调控miR-330-5p-PALM信号轴抑制宫颈癌的发展。
Hereditas. 2025 Jun 18;162(1):108. doi: 10.1186/s41065-025-00478-5.
6
Circular RNA NFIX Functions as an Oncogene in Non-Small Cell Lung Cancer by Modulating the miR-214-3p/TRIAP1 Axis.环状 RNA NFIX 通过调节 miR-214-3p/TRIAP1 轴在非小细胞肺癌中发挥癌基因作用。
Clin Respir J. 2024 Aug;18(8):e13801. doi: 10.1111/crj.13801.
7
The Tumor-Suppressive Role of miR-204-5p Through Targeting Ezrin in Breast Cancer: Experimental Evidence From Cell Lines and Clinical Samples.miR-204-5p通过靶向埃兹蛋白在乳腺癌中的肿瘤抑制作用：来自细胞系和临床样本的实验证据
Clin Breast Cancer. 2025 Jul;25(5):e588-e596. doi: 10.1016/j.clbc.2025.02.013. Epub 2025 Mar 19.
8
Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM.全面的泛癌分析揭示NTN1作为一种免疫浸润风险因素及其在皮肤黑色素瘤中的潜在预后价值。
Sci Rep. 2025 Jan 25;15(1):3223. doi: 10.1038/s41598-025-85444-x.
9
Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients.血清细胞外囊泡微小RNA作为预测转移性非小细胞肺癌患者帕博利珠单抗反应和预后的潜在生物标志物。
Front Immunol. 2025 Jun 4;16:1540906. doi: 10.3389/fimmu.2025.1540906. eCollection 2025.
10
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类：一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.

本文引用的文献

1
Detection of serum SNHG22 and its correlation with prognosis of non-small cell lung cancer.检测血清 SNHG22 及其与非小细胞肺癌预后的相关性。
J Cardiothorac Surg. 2024 Sep 20;19(1):536. doi: 10.1186/s13019-024-03048-4.
2
SH3BP5-AS1/IGF2BP2/VDAC2 Axis Promotes the Apoptosis and Ferroptosis of Bladder Cancer Cells.SH3BP5-AS1/IGF2BP2/VDAC2轴促进膀胱癌细胞的凋亡和铁死亡
Bladder Cancer. 2023 Mar 31;9(1):29-40. doi: 10.3233/BLC-211629. eCollection 2023.
3
LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis.
长链非编码RNA PGM5-AS1通过靶向miRNA-423-5p/SLIT2轴抑制非小细胞肺癌进展。
Cancer Cell Int. 2024 Jun 20;24(1):216. doi: 10.1186/s12935-024-03402-5.
4
LncRNA SH3BP5-AS1 promotes hepatocellular carcinoma progression by sponging miR-6838-5p and activation of PTPN4.长链非编码 RNA SH3BP5-AS1 通过海绵吸附 miR-6838-5p 和激活 PTPN4 促进肝癌进展。
Aging (Albany NY). 2024 May 16;16(10):8511-8523. doi: 10.18632/aging.205811.
5
Identifying lncRNAs and mRNAs related to survival of NSCLC based on bioinformatic analysis and machine learning.基于生物信息学分析和机器学习鉴定与 NSCLC 患者生存相关的 lncRNAs 和 mRNAs。
Aging (Albany NY). 2024 May 1;16(9):7799-7817. doi: 10.18632/aging.205783.
6
TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p.TP53通过介导耐药细胞衍生的外泌体mir-424-5p的作用减轻非小细胞肺癌中的顺铂耐药性。
Heliyon. 2024 Feb 22;10(5):e26853. doi: 10.1016/j.heliyon.2024.e26853. eCollection 2024 Mar 15.
7
Notch signaling and targeted therapy in non-small cell lung cancer. Notch 信号通路与非小细胞肺癌的靶向治疗
Cancer Lett. 2024 Mar 31;585:216647. doi: 10.1016/j.canlet.2024.216647. Epub 2024 Jan 30.
8
Metastasis-related long non-coding RNAs AL359220.1, SH3BP5-AS1 and ZF-AS1 are significant for prognostic assessment of lung adenocarcinoma.转移相关长链非编码 RNA AL359220.1、SH3BP5-AS1 和 ZF-AS1 对肺腺癌的预后评估具有重要意义。
Aging (Albany NY). 2023 Aug 10;15(15):7551-7564. doi: 10.18632/aging.204923.
9
Network Pharmacology and Molecular Docking Analysis of Shufeiya Recipe in the Treatment of Pulmonary Hypertension.舒心方治疗肺动脉高压的网络药理学与分子对接分析。
Biomed Res Int. 2022 Dec 28;2022:7864976. doi: 10.1155/2022/7864976. eCollection 2022.
10
Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application.CRISPR/Cas9 技术抑制核糖体组装因子 PNO1 抑制肺腺癌和 Notch 通路：临床应用。
J Cell Mol Med. 2023 Feb;27(3):365-378. doi: 10.1111/jcmm.17657. Epub 2023 Jan 10.